Amphastar Pharmaceuticals, Inc.
Leadership moves, last update 1 month ago
Pharma biotech · Headquarters United States
Everything we hold on Amphastar Pharmaceuticals, Inc., newest first. Every line links to the filing or report it came from.
- 2026-07-13Headcount Not Stated Leadership moves
Amphastar Pharmaceuticals, Inc. Announces Appointment of New Director
Amphastar Pharmaceuticals appoints a new director to its board, effective immediately, signaling leadership change in the pharma and biotech sector.
- 2026-03-06Headcount Not Stated Leadership moves
Amphastar Pharmaceuticals, Inc. 8-K filing (Item 5.02): officer or director change
Amphastar Pharmaceuticals has new executive employment agreements in place in Rancho Cucamonga. The announcement does not disclose any changes in hiring plans.
- 2025-12-31Pay Change Pay and benefits
AMPHASTAR PHARMACEUTICALS, INC.: $8,309,350 total compensation for the principal executive officer, fiscal year ended 2025-12-31
Top-of-house pay is the anchor the rest of an employer's pay structure is set against, and it is the one compensation figure every US-listed company must publish on the same basis. Read it as a comparable, not as a salary band: it is a single officer's total, including equity awards valued under SEC rules, and it says nothing directly about what a given role pays.
- 2024-12-31Pay Change Pay and benefits
AMPHASTAR PHARMACEUTICALS, INC.: $7,734,759 total compensation for the principal executive officer, fiscal year ended 2024-12-31
Top-of-house pay is the anchor the rest of an employer's pay structure is set against, and it is the one compensation figure every US-listed company must publish on the same basis. Read it as a comparable, not as a salary band: it is a single officer's total, including equity awards valued under SEC rules, and it says nothing directly about what a given role pays.
- 2023-12-31Pay Change Pay and benefits
AMPHASTAR PHARMACEUTICALS, INC.: $7,722,768 total compensation for the principal executive officer, fiscal year ended 2023-12-31
Top-of-house pay is the anchor the rest of an employer's pay structure is set against, and it is the one compensation figure every US-listed company must publish on the same basis. Read it as a comparable, not as a salary band: it is a single officer's total, including equity awards valued under SEC rules, and it says nothing directly about what a given role pays.
- 2022-12-31Pay Change Pay and benefits
AMPHASTAR PHARMACEUTICALS, INC.: $7,477,951 total compensation for the principal executive officer, fiscal year ended 2022-12-31
Top-of-house pay is the anchor the rest of an employer's pay structure is set against, and it is the one compensation figure every US-listed company must publish on the same basis. Read it as a comparable, not as a salary band: it is a single officer's total, including equity awards valued under SEC rules, and it says nothing directly about what a given role pays.
Amphastar Pharmaceuticals, Inc.. Talent Intelligence Tracker, AskTheRecruiter.com. Accessed Aug 20, 2026. https://asktherecruiter.com/blog/talent-intelligence-tracker/company/amphastar-pharmaceuticals/ Licensed CC BY 4.0; every record links to the document behind it.The read-through on each line is our interpretation. The headline and figures come from the linked source. Data licensed CC BY 4.0. Back to the tracker